Search
Farletuzumab
go.drugbank.com/drugs/DB05595InvestigationalFarletuzumab (MORAb-003) is a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer.
MBX-2044
go.drugbank.com/drugs/DB05598InvestigationalMBX-2044 was under investigation in clinical trial NCT00422487 (Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes).
IRX-2
go.drugbank.com/drugs/DB05643InvestigationalIt is being investigated to promote or enhance an anti-cancer immune response.
MLN2704
go.drugbank.com/drugs/DB06513InvestigationalA Phase 1/2 trial (NCT00070837) evaluated the safety, dosage, and pharmacokinetics of MLN2704 in patients with metastatic androgen-independent prostate cancer.
PF-00489791
go.drugbank.com/drugs/DB11736InvestigationalPF-00489791 has been used in trials studying the treatment of Hypertension, Raynaud's Disease, Diabetic Nephropathies, Hypertension, Pulmonary, and Peripheral Vascular Disease.
GSK-1059615
go.drugbank.com/drugs/DB11962InvestigationalGSK1059615 has been used in trials studying the treatment of Lymphoma, Solid Tumours, Endometrial Cancer, Solid Tumor Cancer, and Metastatic Breast Cancer.
PF-04457845
go.drugbank.com/drugs/DB12012InvestigationalPF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence.
Lurtotecan
go.drugbank.com/drugs/DB12222InvestigationalLurtotecan is under investigation in clinical trial NCT00022594 (Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer).
Merestinib
go.drugbank.com/drugs/DB12381InvestigationalMerestinib has been used in trials studying the treatment of Cancer, Solid Tumor, Advanced cancer, ColoRectal Cancer, and Metastatic Cancer, among others.
Gemigliptin
go.drugbank.com/drugs/DB12412InvestigationalGemigliptin has been investigated for the treatment of Cancer and Cisplatin Adverse Reaction.